Vaccine-Mediated Protection
Showing 1 - 25 of >10,000
IsThird Dose of MMRV Vaccine Beneficial for Adult Population in
Not yet recruiting
- Vaccination Failure
- Vaccine Response Impaired
- Serology for antibody levels - Baseline
- +3 more
- (no location specified)
Jun 26, 2023
Immunosuppression, COVID-19 Trial in Madison (NVX-CoV2372)
Not yet recruiting
- Immunosuppression
- COVID-19
- NVX-CoV2372
-
Madison, WisconsinUW School of Medicine and Public Health
Aug 31, 2023
Poliovirus Vaccine, Oral, COVID, Mortality Trial in Bissau (oral polio vaccine + information, Information)
Active, not recruiting
- Poliovirus Vaccine, Oral
- +4 more
- oral polio vaccine + information
- Information
-
Bissau, Guinea-BissauBandim Health Project
Mar 16, 2022
Kidney Transplant Recipients, Liver Transplant Recipients Trial in United States (Pfizer-BioNTech COVID-19 Vaccine Booster,
Recruiting
- Kidney Transplant Recipients
- Liver Transplant Recipients
- Pfizer-BioNTech Bivalent COVID-19 Vaccine
- +3 more
-
San Diego, California
- +14 more
Oct 31, 2022
COVID-19 Trial in Kyiv, Vinnitsa (CpG 1018/Alum-adjuvanted SCB-2019 vaccine, Havrix, Placebo; 0.9% saline)
Terminated
- COVID-19
- CpG 1018/Alum-adjuvanted SCB-2019 vaccine
- +2 more
-
Kyiv, Ukraine
- +3 more
May 19, 2022
Newborn Vaccine Immunogenicity Trial in Fajara, Goroka (Hepatitis B vaccine (HBV), Bacillus Calmette-Guérin (BCG))
Active, not recruiting
- Newborn Vaccine Immunogenicity
- Hepatitis B vaccine (HBV)
- Bacillus Calmette-Guérin (BCG)
-
Fajara, Gambia
- +1 more
Jan 12, 2023
Prostate Cancer, Bladder Cancer, NSCLC Trial in New York, Houston (NY-ESO-1 Plasmid DNA Cancer Vaccine)
Completed
- Prostate Cancer
- +4 more
- NY-ESO-1 Plasmid DNA Cancer Vaccine
-
New York, New York
- +1 more
Oct 3, 2022
Bullous Dermatoses, Psoriasis, COVID-19 Vaccines Trial in Ratchathewi (tozinameran)
Recruiting
- Bullous Dermatoses
- +2 more
- tozinameran
-
Ratchathewi, Bangkok, ThailandDermatology outpatient clinic, Somdech Phra Debaratana Medical C
Aug 22, 2022
BCG Vaccination on Infectious and Immune Mediated Diseases
Enrolling by invitation
- BCG Vaccination Reaction
- +3 more
- BCG
- Placebo vaccine
-
Nijmegen, Gelderland, NetherlandsRadboud university medical center
Oct 25, 2022
Kidney Transplant Recipients Trial in Baltimore (mRNA-1273 vaccine (Pfizer/BioNTech), mRNA-1273 vaccine (Moderna))
Active, not recruiting
- Kidney Transplant Recipients
- mRNA-1273 vaccine (Pfizer/BioNTech)
- mRNA-1273 vaccine (Moderna)
-
Baltimore, MarylandJohns Hopkins Hospital
Oct 4, 2021
Covid19 Trial (hAd5-S-Fusion+N-ETSD vaccine)
Withdrawn
- Covid19
- hAd5-S-Fusion+N-ETSD vaccine
- (no location specified)
Dec 14, 2021
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Carcinoma, Locally
Recruiting
- Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +5 more
- Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
- Pembrolizumab
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Vaccine Refusal, COVID-19 Trial (Informational Video, Altruistic Video, Individualistic Video)
Not yet recruiting
- Vaccine Refusal
- COVID-19
- Informational Video
- +2 more
- (no location specified)
Apr 12, 2023
Invasive Pneumococcal Disease, Protection Against, Streptococcus Pneumoniae Infection Trial in Vancouver (PCV13)
Active, not recruiting
- Invasive Pneumococcal Disease, Protection Against
- Streptococcus Pneumoniae Infection
- PCV13
-
Vancouver, British Columbia, CanadaVaccine Evaluation Center (University of BC at Children's Hospit
May 17, 2022
Cystic Fibrosis, Bronchiectasis Adult, Non-Tuberculous Mycobacteria Trial in Baltimore (BCG TICE Vaccine)
Recruiting
- Cystic Fibrosis
- +2 more
- BCG TICE Vaccine
-
Baltimore, MarylandJohns Hopkins University
Jan 26, 2022
Hepatitis B Trial in Finland (HBVAXPRO™)
Completed
- Hepatitis B
- HBVAXPRO™
-
Kokkola, Mellersta Osterbotten, Finland
- +9 more
Jul 20, 2022
Shigella Trial in Baltimore (SF2a-TT15 Shigella Vaccine, Placebo, S. flexneri 2a strain 2457T Challenge Agent)
Recruiting
- Shigella
- SF2a-TT15 Shigella Vaccine
- +2 more
-
Baltimore, MarylandUniversity of Maryland, Baltimore, Center for Vaccine Developmen
May 5, 2022
COVID-19 Antibody Levels After Vaccines
Completed
- Vaccine Preventable Disease
- COVID-19 Vaccination
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill
Jul 28, 2022
Vaccine Trial in Jakarta (Vi-DT Typhoid Conjugate Vaccine)
Recruiting
- Vaccine
- Vi-DT Typhoid Conjugate Vaccine
-
Jakarta, Indonesia
- +1 more
Jul 16, 2021
Chronic Hepatitis, Hepatitis C Infection Trial in Puerto Rico, United States (Electroporation-Mediated Plasmid DNA Vaccine
Active, not recruiting
- Chronic Hepatitis
- Hepatitis C Infection
- Electroporation-Mediated Plasmid DNA Vaccine Therapy
- +4 more
-
Jacksonville, Florida
- +4 more
Sep 20, 2022
The Durability of Protection and Immuno-persistence Study
Recruiting
- Cervical Intraepithelial Neoplasia
- +4 more
- Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli)
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Sep 14, 2021
Influenza Viral Infections Trial in Dhaka, Trondheim (Inactivated influenza vaccine, Inactivated polio vaccine)
Enrolling by invitation
- Influenza Viral Infections
- Inactivated influenza vaccine
- Inactivated polio vaccine
-
Dhaka, Bangladesh
- +1 more
Aug 1, 2021
Covid19 Trial (hAd5-S-Fusion+N-ETSD vaccine)
Withdrawn
- Covid19
- hAd5-S-Fusion+N-ETSD vaccine
- (no location specified)
Dec 14, 2021
Covid-19, Protection Against COVID-19 Trial in Berlin, Mannheim (BNT162b3)
Completed
- Covid-19
- Protection Against COVID-19
- BNT162b3
-
Berlin, Germany
- +1 more
Jun 24, 2022
Vaccine Preventable Disease Trial in Hamilton (COVID-19 Vaccination, Usual care)
Withdrawn
- Vaccine Preventable Disease
- COVID-19 Vaccination
- Usual care
-
Hamilton, Ontario, CanadaMcMaster University
May 12, 2021